Nomura Holdings Inc Novo Nordisk A S Call Options Transaction History

Nomura Holdings Inc

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $297,675 - $363,549	2,500 New	2,500 $297,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $10.2 Million - $13.5 Million	99,600 New	99,600 $12.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $5.54 Million - $6.65 Million	63,100 Added 315.5%	83,100 $8.6 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $1.82 Million - $3.99 Million	20,000 New	20,000 $1.82 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $10.9 Million - $13.1 Million	82,400 New	82,400 $13.1 Million
Q3 2022 Nov 15, 2022	BUY	$95.28 - $116.93 $5.27 Million - $6.47 Million	55,300 New	55,300 $5.51 Million
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $2.37 Million - $3 Million	-28,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $2.25 Million - $2.82 Million	-33,300 Reduced 54.23%	28,100 $2.36 Million
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $2.92 Million - $3.28 Million	61,400 New	61,400 $3.11 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.